Acupoint Focused Ultrasound Versus Laserpuncture In Mechanical Neck Pain
Unknown statusNot applicableNCT05782621
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
this study will be conducted to compare the effect of Acupoint focused ultrasound and Laser puncture on pain intensity level, neck range of motion, and neck function in patient with chronic mechanical neck pain
Study details
- Official title
- Acupoint Focused Ultrasound Versus Laserpuncture In Chronic Mechanical Neck Pain
- Conditions
- Interventions
- Other: Acupoint focused ultrasound
- Other: Laserpuncture
- Other: conventional treatment
- Sponsor
- Cairo University
- Start date
- 2023-03-30
- Primary completion
- 2023-05-30
- Sex
- All
- Age range
- from 30 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: All subjects will be referred by the orthopedist. Cervical pain is episodic chronic, having occurred and recurred over regular or irregular intervals of time over at least the last 3 months. The subject is willing and able to refrain from non-study procedure therapies for the management of neck pain throughout study participation. Age ranged from 30-60 years BMI ranged from (25-30kg/m2) Exclusion Criteria: Cervical pain is undiagnosed or has been diagnosed as being other than of benign musculoskeletal origin. Tension myositis syndrome. Osteoporosis with compression fractures. Congenital deformity of spine. Current active chronic pain disease. Cancer or cancer treatment in the past 6 months. Use of the following analgesics within 7 days of study onset - paracetamol, acetominophen, non-steroidal anti-inflammatory drugs (NSAIDs), compound analgesics, topical analgesics. Use of the following muscle relaxants within the prior 30 days of study onset - cyclobenzaprine, diazepam, meprobamate.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05782621